146 related articles for article (PubMed ID: 36863017)
1. Interstitial fluid flow contributes to prostate cancer invasion and migration to bone; study conducted using a novel horizontal flow bioreactor.
Jasuja H; Jaswandkar SV; Katti DR; Katti KS
Biofabrication; 2023 Mar; 15(2):. PubMed ID: 36863017
[TBL] [Abstract][Full Text] [Related]
2. CXCL12-CXCR4 interactions modulate prostate cancer cell migration, metalloproteinase expression and invasion.
Singh S; Singh UP; Grizzle WE; Lillard JW
Lab Invest; 2004 Dec; 84(12):1666-76. PubMed ID: 15467730
[TBL] [Abstract][Full Text] [Related]
3. Perfusion bioreactor enabled fluid-derived shear stress conditions for novel bone metastatic prostate cancer testbed.
Jasuja H; Kar S; Katti DR; Katti KS
Biofabrication; 2021 Apr; 13(3):. PubMed ID: 33418550
[TBL] [Abstract][Full Text] [Related]
4. TGF-β Effects on Prostate Cancer Cell Migration and Invasion Require FosB.
Barrett CS; Millena AC; Khan SA
Prostate; 2017 Jan; 77(1):72-81. PubMed ID: 27604827
[TBL] [Abstract][Full Text] [Related]
5. The importance of the CXCL12-CXCR4 chemokine ligand-receptor interaction in prostate cancer metastasis.
Arya M; Patel HR; McGurk C; Tatoud R; Klocker H; Masters J; Williamson M
J Exp Ther Oncol; 2004 Dec; 4(4):291-303. PubMed ID: 15844659
[TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factor A, secreted in response to transforming growth factor-β1 under hypoxic conditions, induces autocrine effects on migration of prostate cancer cells.
Darrington E; Zhong M; Vo BH; Khan SA
Asian J Androl; 2012 Sep; 14(5):745-51. PubMed ID: 22705563
[TBL] [Abstract][Full Text] [Related]
7. Bone sialoprotein stimulates focal adhesion-related signaling pathways: role in migration and survival of breast and prostate cancer cells.
Gordon JA; Sodek J; Hunter GK; Goldberg HA
J Cell Biochem; 2009 Aug; 107(6):1118-28. PubMed ID: 19492334
[TBL] [Abstract][Full Text] [Related]
8. TGF-β effects on prostate cancer cell migration and invasion are mediated by PGE2 through activation of PI3K/AKT/mTOR pathway.
Vo BT; Morton D; Komaragiri S; Millena AC; Leath C; Khan SA
Endocrinology; 2013 May; 154(5):1768-79. PubMed ID: 23515290
[TBL] [Abstract][Full Text] [Related]
9. CXCR4 pharmacogical inhibition reduces bone and soft tissue metastatic burden by affecting tumor growth and tumorigenic potential in prostate cancer preclinical models.
Gravina GL; Mancini A; Muzi P; Ventura L; Biordi L; Ricevuto E; Pompili S; Mattei C; Di Cesare E; Jannini EA; Festuccia C
Prostate; 2015 Sep; 75(12):1227-46. PubMed ID: 26073897
[TBL] [Abstract][Full Text] [Related]
10. SLUG promotes prostate cancer cell migration and invasion via CXCR4/CXCL12 axis.
Uygur B; Wu WS
Mol Cancer; 2011 Nov; 10():139. PubMed ID: 22074556
[TBL] [Abstract][Full Text] [Related]
11. Reduced FRG1 expression promotes prostate cancer progression and affects prostate cancer cell migration and invasion.
Tiwari A; Mukherjee B; Hassan MK; Pattanaik N; Jaiswal AM; Dixit M
BMC Cancer; 2019 Apr; 19(1):346. PubMed ID: 30975102
[TBL] [Abstract][Full Text] [Related]
12. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
13. Expression and functional role of CCR9 in prostate cancer cell migration and invasion.
Singh S; Singh UP; Stiles JK; Grizzle WE; Lillard JW
Clin Cancer Res; 2004 Dec; 10(24):8743-50. PubMed ID: 15623660
[TBL] [Abstract][Full Text] [Related]
14. Osteoblast conditioned media contain TGF-beta1 and modulate the migration of prostate tumor cells and their interactions with extracellular matrix components.
Festuccia C; Bologna M; Gravina GL; Guerra F; Angelucci A; Villanova I; Millimaggi D; Teti A
Int J Cancer; 1999 May; 81(3):395-403. PubMed ID: 10209954
[TBL] [Abstract][Full Text] [Related]
15. Regulation of prostate cancer cell migration toward bone marrow stromal cell-conditioned medium by Wnt5a signaling.
Jin F; Qu X; Fan Q; Wang L; Tang T; Hao Y; Dai K
Mol Med Rep; 2013 Nov; 8(5):1486-92. PubMed ID: 24064566
[TBL] [Abstract][Full Text] [Related]
16. Interaction of ligand-receptor system between stromal-cell-derived factor-1 and CXC chemokine receptor 4 in human prostate cancer: a possible predictor of metastasis.
Mochizuki H; Matsubara A; Teishima J; Mutaguchi K; Yasumoto H; Dahiya R; Usui T; Kamiya K
Biochem Biophys Res Commun; 2004 Jul; 320(3):656-63. PubMed ID: 15240098
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of HMGA2 inhibits cellular proliferation and invasion, improves cellular apoptosis in prostate cancer.
Cai J; Shen G; Liu S; Meng Q
Tumour Biol; 2016 Jan; 37(1):699-707. PubMed ID: 26242267
[TBL] [Abstract][Full Text] [Related]
18. CXCL12/CXCR4 signaling activates Akt-1 and MMP-9 expression in prostate cancer cells: the role of bone microenvironment-associated CXCL12.
Chinni SR; Sivalogan S; Dong Z; Filho JC; Deng X; Bonfil RD; Cher ML
Prostate; 2006 Jan; 66(1):32-48. PubMed ID: 16114056
[TBL] [Abstract][Full Text] [Related]
19. [Effects of the Rho-kinase inhibitor fasudil on the invasion, migration, and apoptosis of human prostate cancer PC3 and DU145 cells].
Gao QQ; Chen H; Chen Y; Xu ZP; Zhu LL; Yu W; Han YF; Dai YT
Zhonghua Nan Ke Xue; 2016 Jun; 22(6):483-490. PubMed ID: 28963834
[TBL] [Abstract][Full Text] [Related]
20. TERF1 downregulation promotes the migration and invasion of the PC3 prostate cancer cell line as a target of miR‑155.
Chen W; He LN; Liang Y; Zeng X; Wu CP; Su MQ; Cheng Y; Liu JH
Mol Med Rep; 2020 Dec; 22(6):5209-5218. PubMed ID: 33174061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]